Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein-protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells

Publication date: Available online 10 July 2021Source: Genes & DiseasesAuthor(s): Shasha Cheng, Guan-Jun Yang, Wanhe Wang, Dik-Lung Ma, Chung-Hang Leung
Source: Genes and Diseases - Category: Genetics & Stem Cells Source Type: research